We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Discovery of Pain Receptor on T-cells Could Help Treat Autoimmune Disorders

By LabMedica International staff writers
Posted on 19 Oct 2014
Print article
Inflammatory response and damage to the intenstinal wall (left) could be prevented by injecting TRPV1-deficient T-cells (right). Photo courtesy of Nature Immunulogy, Bertin et al.).
Inflammatory response and damage to the intenstinal wall (left) could be prevented by injecting TRPV1-deficient T-cells (right). Photo courtesy of Nature Immunulogy, Bertin et al.).
Researchers have discovered that T-cells are activated by a pain receptor. The new findings revealed that the receptor helps control intestinal inflammation in mice and that its activity can be adjusted, providing a potential new target for treating certain autoimmune disorders, such as Crohn’s disease and possibly multiple sclerosis.

The study’s findings were published online October 5, 2014, in the journal Nature Immunology. “We have a new way to regulate T-cell activation and potentially better control immune-mediated diseases,” said senior author Eyal Raz, MD, professor of medicine at the University of California, San Diego School of Medicine (USA).

The receptor, called a TRPV1 channel, has a well-recognized role on nerve cells that help regulate body temperature and alert the brain to heat and pain. It is also called the capsaicin receptor because of its role in creating the sensation of heat from chili peppers.

The study is the first to show that these channels are also present on T-cells, where they are involved in gating the influx of calcium ions into cells—a process that is required for T-cell activation. “Our study breaks current dogma in which certain ion channels called CRAC are the only players involved in calcium entry required for T-cell function,” said lead author Samuel Bertin, a postdoctoral researcher in the Raz laboratory. “Understanding the physical structures that enable calcium influx is critical to understanding the body’s immune response.”

T-cells are targeted by the HIV virus and their destruction is why individuals with AIDS have compromised immune function. Specific vaccines also harness T-cells by exploiting their ability to recognize antigens and trigger the production of antibodies, conferring disease resistance. Allergies, in contrast, may occur when T-cells recognize harmless substances as pathogenic.

TRPV1 channels appear to offer a way to manipulate T-cell response as needed for health. Specifically, in in-vitro experiments, researchers showed that T-cell inflammatory response could be reduced by knocking down the gene that encodes for the protein that comprises the TRPV1 channel. Overexpression of this gene was shown to lead to a surge in T-cell activation, which in human health may contribute to autoimmune diseases. T-cells also responded to pharmaceutical agents that block or activate the TRPV1 channel.

In research using mice models, researchers were able to reduce colitis with a TRPV1-blocker, initially developed as a new painkiller. One of the exciting discoveries is that colitis in mice could be treated with much lower doses than what is needed to dull pain. “This suggests we could potentially treat some autoimmune diseases with doses that would not affect people's protective pain response,” Dr. Raz said.

Related Links:

University of California, San Diego School of Medicine


Gold Member
Turnkey Packaging Solution
HLX
Automated Blood Typing System
IH-500 NEXT
New
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Chemistry Analyzer
MS100

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.